Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in LFCR — Lifecore Biomedical, Inc. De

CIK 1595888 NEW YORK, NY
Back to LFCR Full portfolio

Position in LFCR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$152,649
-$824,410 QoQ
Shares Held
29,076
-75.7% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 98 holders
Holding Since
Jun 2021
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LFCR Over Time

Shares Held

Position Value (USD)

Derivatives in LFCR

reported options exposure · as of Dec 31, 2025
CallValue
$83,436
CallShares
10,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $557,642,679 across 56 Drug Manufacturers - Specialty & Generic names. LFCR ranks #39 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 285,926 $154,923,283
2 ZTS
Zoetis Inc.
 2,011,337 $144,534,676
3 VTRS
Viatris Inc
 5,569,311 $88,440,657
4 HIMS
Hims & Hers Health, Inc.
 1,000,484 $34,686,779
5 HLN
Haleon plc
 3,669,116 $34,232,851
6 BCRX
Biocryst Pharmaceuticals Inc
 2,762,683 $27,626,830
7 TRLV
Trulieve Cannabis Corp.
 1,212,526 $11,919,129
8 LQDA
Liquidia Corp
 141,541 $11,285,063

All Filings in LFCR

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $152,649 29,076
2025-12-31 $83,436 10,200
2025-12-31 $977,059 119,445
2025-09-30 $487,761 66,272
2024-09-30 $178,692 36,246
2024-06-30 $92,180 17,969
2024-03-31 $1,569,566 295,587
2023-12-31 $843,263 136,230
2023-09-30 $267,111 35,379
2023-06-30 $918,166 94,950
2021-06-30 $165,926 14,749